Introduction: It has been demonstrated how early postoperative monitoring and rehabilitation protocols provide better recovery of continence and erectile function in patient underwent RARP, but their adoption is limited by the lack of human resources and local services. The aim of this research was to investigate patient and providers satisfaction in the use of a new telemedicine (TM) platform designed for telemonitoring and telerehabilitation of patient undergoing RARP. Methods: We worked with software engineers to modify and implement the existing MAIA TM platform (ab medica s.p.a.). The TM system consists of an online platform that enables the acquisition, management and archiving of perioperative data and makes it possible to define a treatment plan and monitor the clinical response of rehabilitation activities. By means of an App for SmartPhone and Tablet devices, it is possible to receive notifications for medication and/or rehabilitation exercises and to upload information for monitoring clinical parameters (such as validated questionnaires or PAD tests). Patients undergoing RARP at our institution in September 2022 who had access to the Internet were included in this first part of the study. Patient satisfaction was measured using the Telemedicine Satisfaction Questionnaire (TSQ; range 1-5) and a visual analogue scale (VAS; range 0-100) after 30 days of use. Technical problems and platform/app malfunctions were recorded. Results: 28 patients and 3 providers were enrolled in this first phase of the study. Patients and providers mean (SD) VAS satisfaction scores were 88.7 (17.2) and 82.2 (11.2), respectively. The mean (SD) TSQ score was 4.6 (0.4), all 28 patients reported they would use this new telemedicine platform again and would recommend it to other people. 10/28 (35.7%) patients reported App technical issues, namely 6 (21.4%) notification malfunctions and 4 (14.2%) online questionnaires filling failures. All these issues were easily solved by changing the smartphone's accessibility settings. Providers reported no technical malfunctions of the online MAIA platform. Conclusions: Our new TM MAIA platform specifically designed for telemonitoring and telerehabilitation of patients undergoing RARP appears to be user-friendly and shows a high level of satisfaction among both patients and providers. The prosecution of this study will be necessary to evaluate the long-term satisfaction and clinical effectiveness of this TM platform. SOURCE OF Funding: None
